“These findings suggest that changing the genetic testing paradigm to population-based testing could prevent thousands of breast and ovarian cancers," experts wrote in JAMA. 

Rep. Greg Murphy, MD, R-N.C., unveiled the No Surprises Enforcement Act on Sept. 13, joined by Reps. Raul Ruiz, MD, D-Calif., and John Joyce, MD, R-Penn. 

Continued declines in reimbursement and mounting administrative burdens are combining to weigh down members of the specialty, RP wrote in recent comments. 

One critical access hospital in North Dakota is treating upward of 20 Canadian patients per month, the CBC reports. 

Medicare wants to limit the technical component for the exam to the HOPPS rate, which would represent an 81% reduction to the MPFS amount of $459.92. 

“Congress must act before the end of 2024 to provide clinicians with the financial stability needed to ensure beneficiaries continue to have access to high-quality care,” the groups wrote. 

Breast scanner-maker QT Imaging first started trading its shares in March following a long-delayed merger deal and related lawsuit. 

U.S. Rep. Rosa DeLauro, D-Conn., convened the hearing a day before new FDA breast density notification requirements were set to go into effect on Sept. 10.